Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

03:57 EDT 23rd October 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,500+

Thursday 23rd October 2014

Novartis AIN457 (secukinumab) meets primary endpoint in two Phase III studies in ankylosing spondylitis, a debilitating joint condition of the spine

Novartis International AG / Novartis AIN457 (secukinumab) meets primary endpoint in two Phase III studies in ankylosing spondylitis, a debilitating joint condition of the spine . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Secukinumab is the first selective IL-17A inhibitor to meet primary endpoint in two pi...

Mesothelioma Victims Center Points To New Study From NSCIC That Sheds Light On Workgroups Most Impacted By This Rare Cancer

This week the Mesothelioma Victims Center is sharing a new study from the UK's NSCIC that focuses on workgroups such as plumbers, electricians, or maritime workers who could have been exposed to asbestos as very important information for families whose medical doctor has hinted at or mentioned mesothelioma. The Center says, "If your physician has said mesothelioma is a possibility, but th...

Genomic sequencing more efficient in predicting breast cancer risk than previously thought

Using genomic sequencing data on all currently known genetic alterations in breast cancer, it is possible to identify a woman’s genetic risk for the disease, and this approach can bring greater gains in disease prevention than previously estimated,...

Wednesday 22nd October 2014

South Nassau Communities Hospital Closes Acquisition of LBMC Assets

Oceanside, NY, October 23, 2014 --(PR.com)-- South Nassau Communities Hospital has closed on an asset purchase agreement (APA) to acquire substantially all of the assets of Long Beach Medical Center (LBMC), which had been severely damaged by the effects of Super Storm Sandy and had remained shuttered since October 2012. Under the Asset Purchase Agreement (“APA”) approved by the US Ban...

WuXi PharmaTech and Foundation Partner to Offer Cancer Test in China

WuXi PharmaTech formed a collaboration with Foundation Medicine of Cambridge, MA that will offer the FoundationOne® assay in China. The assay tests for genetic abnormalities associated with cancer to determine the best treatment. For pharmas unde...

Tryptophan catabolism is unaffected in chronic granulomatous disease

Arising from L. Romani et al.Nature451,211–215 (2008); doi:10.1038/nature06471Chronic granulomatous disease (CGD) is an inherited disorder of phagocyte function, caused by a genetic defect in NADPH oxidase (NOX2), leading to an impaired ability of ...

The ‘mitoflash’ probe cpYFP does not respond to superoxide

Arising from E.-Z. Shen et al.Nature508, 128–132 (2014); doi:10.1038/nature13012Ageing and lifespan of organisms are determined by complicated interactions between their genetics and the environment, but the cellular mechanisms remain controversial...

Cancer: Immunotherapy beats leukaemia

Engineering certain immune cells to kill cancerous cells in leukaemia has driven the disease into remission for up to two years in more than half of participants in an early-stage clinical trial.Stephan Grupp at the Children's Hospital of Philadelphi...

Atossa Genetics receives CE mark for ForeCYTE Breast Aspirator device

Atossa Genetics announced it has received certification to Annex II of the European Medical Device Directive (MDD) from its European Notified Body, DQS Medizinprodukte GmbH, which allows Atossa to place the "CE" Mark on the ForeCYTE Breast Aspirator ...

Golden Office Trailers Gives Back to Community at Lake Elsinore Relay for Life

Golden Office Trailers supports American Cancer Society fund raiser with registration trailer and year-long commitment. Lake Elsinore, CA (PRWEB) October 22, 2014 Local small business Golden Office Trailers supported the American Cancer Society’s Relay for Life by donating an office trailer for use at the Lake Elsinore Relay for Life event held at Canyon Lake Middle School, October 11 – 12, a...

Genetic evidence of hybridization between the critically endangered Cuban crocodile and the American crocodile: implications for population history and in situ/ex situ conservation

Genetic architecture of resistance in Daphnia hosts against two species of host-specific parasites

Standard Process Inc. Distinguishes itself as an Exemplary Environmental Citizen

Wisconsin Department of Natural Resources welcomes Standard Process to the Green Tier program (PRWEB) October 22, 2014 Wisconsin Department of Natural Resources (DNR) Secretary Cathy Stepp and other DNR officials visited Standard Process Inc. yesterday to recognize the supplement manufacturer as a new member of the state’s Green Tier program. The Green Tier program recognizes companies that dis...

Zymeworks Inc. Announces over-Subscription of Previously Announced Private Placement in Conjunction with the Expansion of a Strategic Collaboration

Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the close and over-subscription of a previously announced private placement. The financing included investments from new and existing shareholders, and extended the total gross proceed...

Transgenomic Announces $2.375 Million Private Placement Financing

Transgenomic, Inc. (NASDAQ: TBIO) announced today that it has raised gross proceeds of approximately $2.375 million in a private placement financing with a syndicate of new and existing institutional and other accredited investors. The Company’s common shares were priced at $3.25 per share, which represents a premium to the closing stock price on Oct...

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

LONDON, Oct. 22, 2014 /PRNewswire/ -- North America autoimmune disease diagnostics market is estimated to reach $7.09 billion in 2020 from $5.504 billion in 2014 with a CAGR 5.24%. The term "autoimmune disease" refers to a varied group of illnesses that involve almost every human organ system. U.S being the largest market for autoimmune treatments holds 43% share in the global market, it will...

Genetic Testing Market Outlook 2018

LONDON, Oct. 22, 2014 /PRNewswire/ -- A recent report, "Genetic Testing Market Outlook 2018", provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in this report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges;...

MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors

LONDON, Oct. 22, 2014 /PRNewswire/ -- This report covers the specifics of microRNA (miRNA) as it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect genetic expression make it a novel candidate for use as a biomarker for a variety of diseas...

GLP Development Co. Begins $17.8 Million Building Project in Innovation Park at Penn State Bringing its Total Investment in High-Demand Park to $56 Million

Tuesday, October 21st, GLP 331 IP of Baltimore, led by GLP Development Company, broke ground on 331 Innovation Boulevard in Innovation Park at Penn State in University Park (State College), Pennsylvania. The four-story, 82,000 square feet, LEED-certified building, scheduled for completion August 2015, signals both high demand and new levels of collaboration between Penn State and the area business...

Worcester Polytechnic Institute Study Shows Paralyzed Patients Have Weaker Bones and a Higher Risk of Fractures than Expected

Study by team at Worcester Polytechnic Institute shows standard bone density scans may underestimate the fracture risk for spinal cord injury patients and, by extension, those with osteoporosis. Worcester, Mass. (PRWEB) October 22, 2014 People paralyzed by spinal cord injuries lose mechanical strength in their leg bones faster, and more significantly, than previously believed, putting them at gre...

FIU scientists to use tiny particles to fight big diseases

MIAMI, Oct. 22, 2014 /PRNewswire-USNewswire/ -- Physicians will tell you: They are not winning the war on ovarian cancer. But Florida International University researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering to create a smarter, more targeted therapy that could overcome the most lethal gynecologic c

Genetics underpin bullying victimisation influence on paranoia

Bullying victimisation in childhood may indicate genetic risk for later psychosis, rather than being an environmental trigger, say UK researchers.

Genome Assembler Selection Made Easier

One of the challenges for researchers after the sequencing of genetic code is to find the appropriate assembler. This is a challenge because of the several factors that need to be considered upon assembling DNA fragments. This problem is being addressed by the use of a repository of genome assemblers, http://nucleotide.es, developed by Michael Bart...

Restoring Extinct Species through Genetic Engineering

Harvard geneticist, George Church is working on a study about restoring mammoth through the use of genetic engineering in Asian elephant, the closer relative of mammoth than African elephant. According to Church, this can be done by increasing the cold tolerance of Asian elephants which will require several changes in the traits of Asian elephants....

Sangamo BioSciences Reports Third Quarter 2014 Financial Results

RICHMOND, Calif., Oct. 22, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its third quarter 2014 financial results and accomplishments. For the third quarter ended September 30, 2014, Sangamo reported a consolidated net loss of $7.5 million, or $0.11 per share, compared to a net loss of $6.1 million, or $0.11 per share, for the same period in 2013. As of Septem...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks